Vernacare International, pioneers in sustainable manufacturing for Infection Prevention, Clinical Waste Management, and Surgical Solutions, has finalised the acquisition of Splice Cast Limited, a market leader in the vaginal speculum market. 

The acquisition, completed for an undisclosed sum, signifies Vernacare's strategic intention to strengthen its presence in the Women’s Health sector. Alex Hodges, CEO of Vernacare International stated, "This acquisition marks a significant milestone for Vernacare International, as it amplifies our presence and offerings aimed at protecting and improving women's health. We are enthusiastic about the opportunities and the value it will bring to our organisation and customers."

Hodges continued, “The acquisition of Splice Cast bolsters Vernacare International’s UK manufacturing capabilities, further demonstrating our commitment to providing superior product quality and supply chain resilience to our customers around the world.”

Established in Newtown, Wales in 2000, Splice Cast has earned a distinguished reputation for its market-driven approach to product development. The company has developed an innovative range of unbreakable speculums under the Ultraspec and EcoGold brands that provide the benefit of comfort and safety for the patient.  

With this strategic acquisition, Vernacare reinforces its commitment to delivering comprehensive healthcare solutions. It expands Vernacare International’s presence in women’s health, with an emphasis on products that play an integral role in cervical screening procedures, significantly contributing to accurate diagnoses and timely interventions.